Coletiva de imprensa: anúncio do Governo - 17/02/2021
Date:
17/02/2021
O Governador João Doria confirmou nesta quarta-feira (17) que o Instituto Butantan vai antecipar a entrega de mais 54 milhões de doses da vacina contra o coronavírus ao Ministério da Saúde. A oferta da carga adicional de imunizantes será finalizada em agosto, totalizando 100 milhões de vacinas produzidas em São Paulo para todo o Brasil.
“Inicialmente prevista para o final de setembro, a ...
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Local Health Systems/organization & administration, Schools/organization & administration, Psychology, Educational/organization & administration, Social Isolation, Masks, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Epidemiological Monitoring, Risk Groups, COVID-19, Plano São Paulo, Doria, João, Instituto Butantan, Sinovac Biotech, Coronavac, Município de Serrana , Projeto S, Psicólogos na escola
Coletiva de imprensa: anúncios do Governo SP - 17/12/2020
Date:
17/12/2020
O Governador João Doria anunciou a chegada, nesta quinta-feira (17), de 2 milhões de doses prontas da vacina contra o coronavírus, a Coronavac, desenvolvida em parceria com o Instituto Butantan. Trata-se do maior lote de vacinas que chega à América do Sul até o momento.
“A pressa pela vacina é a pressa pela vida. Todos os brasileiros de bem têm pressa. São Paulo, reafirmo aqui, começar...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Brazilian Health Surveillance Agency, Holidays, Epidemiological Monitoring, Clinical Trial, Phase III, Immunization Programs/organization & administration, Public-Private Sector Partnerships/organization & administration, Risk Groups, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Local Health Systems/organization & administration, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Masks, Social Isolation, Schools/standards, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech
Coletiva de imprensa: anúncios do Governo SP - 14/12/2020
Date:
14/12/2020
O Governador João Doria confirmou nesta segunda-feira (14) que o estudo clínico conclusivo da vacina do Instituto Butantan contra o coronavírus será divulgado no dia 23 de dezembro. A medida dá mais agilidade aos trâmites de certificação na Anvisa (Agência Nacional de Vigilância Sanitária) e demais órgãos internacionais de saúde.
“Os brasileiros querem agilidade, querem as vacinas ...
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Betacoronavirus/immunology, Epidemiological Monitoring, Immunization Programs/organization & administration, Brazilian Health Surveillance Agency, Clinical Trial, Phase III, Viral Vaccines/supply & distribution, Viral Vaccines/immunology, Healthy Volunteers, Governmental Research Institutes, Risk Groups, Police/organization & administration, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Pandemics/statistics & numerical data, Social Isolation, Masks, COVID-19, Plano São Paulo, Coronavac, Instituto Butantan, Sinovac Biotech
Coletiva de imprensa: anúncios da Saúde no combate ao Coronavírus
Date:
11/12/2020
Saiba mais em www.saopaulo.sp.gov.br/coronavirus/vacina
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Epidemiological Monitoring, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Risk Groups, Masks, Social Isolation, Local Health Systems/organization & administration, Healthcare Financing, Quarantine/organization & administration, Commerce/organization & administration, Carrier State/transmission, Brazilian Health Surveillance Agency, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech
PAHO information session for the press on COVID-19 - December 9, 2020
Date:
09/12/2020
PAHO information session for the press on COVID-19 - December 9, 2020 - audio english
See more details
Coronavirus Infections/mortality, Pneumonia, Viral/mortality, Pandemics/prevention & control, Epidemiological Monitoring, 50207, Health Systems/organization & administration, Americas/epidemiology, Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Viral Vaccines/supply & distribution, Mass Vaccination/organization & administration, Social Isolation, Masks/supply & distribution, Cyclonic Storms, Seasons, Hospital Bed Capacity, Intensive Care Units/supply & distribution, Hospitals/supply & distribution, Holidays, Healthcare Financing, Access to Essential Medicines and Health Technologies, Risk Groups, Health Promotion, Community Health Workers, Polymerase Chain Reaction/statistics & numerical data, Gift Giving, Health Human Resource Training, Personal Protective Equipment/supply & distribution, Vulnerable Populations, COVID-19, Etienne, Carissa F, Covax
Sesión virtual informativa de la OPS sobre COVID-19
Date:
09/12/2020
Sesión virtual informativa de la OPS sobre COVID-19 / PAHO’s press briefing on COVID-19 - audio floor
See more details
Coronavirus Infections/mortality, Pneumonia, Viral/mortality, Pandemics/prevention & control, Epidemiological Monitoring, 50207, Health Systems/organization & administration, Americas/epidemiology, Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Viral Vaccines/supply & distribution, Mass Vaccination/organization & administration, Social Isolation, Masks/supply & distribution, Cyclonic Storms, Seasons, Hospital Bed Capacity, Intensive Care Units/supply & distribution, Hospitals/supply & distribution, Holidays, Healthcare Financing, Access to Essential Medicines and Health Technologies, Risk Groups, Health Promotion, Community Health Workers, Polymerase Chain Reaction/statistics & numerical data, Gift Giving, Health Human Resource Training, Personal Protective Equipment/supply & distribution, Vulnerable Populations, COVID-19, Etienne, Carissa F, Covax
Conferencia de prensa OPS COVID-19 - 9 de diciembre 2020
Date:
09/12/2020
Conferencia de Prensa OPS COVID-19 9 de diciembre 2020 - audio español
See more details
Coronavirus Infections/mortality, Pneumonia, Viral/mortality, Pandemics/prevention & control, Epidemiological Monitoring, 50207, Health Systems/organization & administration, Americas/epidemiology, Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Viral Vaccines/supply & distribution, Mass Vaccination/organization & administration, Social Isolation, Masks/supply & distribution, Cyclonic Storms, Seasons, Hospital Bed Capacity, Intensive Care Units/supply & distribution, Hospitals/supply & distribution, Holidays, Healthcare Financing, Access to Essential Medicines and Health Technologies, Risk Groups, Health Promotion, Community Health Workers, Polymerase Chain Reaction/statistics & numerical data, Gift Giving, Health Human Resource Training, Personal Protective Equipment/supply & distribution, Vulnerable Populations, COVID-19, Etienne, Carissa F, Covax
Media briefing on COVID-19 - 04/12/2020
Date:
04/12/2020
00:00:26
TJ Good evening, everyone, from Geneva, WHO headquarters. My name is Tarik and I'm happy to be back at these press conferences; it's been five months. Welcome to another regular WHO COVID-19 press briefing. We have a number of speakers here in the room but also we will have some guests whom Dr Tedros will introduce in a moment. In the room with us we have WHO Director-General, D...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Epidemiological Monitoring, Social Isolation, Masks, Americas/epidemiology, Betacoronavirus/immunology, Viral Vaccines/supply & distribution, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Hospital Bed Capacity, Intensive Care Units/supply & distribution, Hospitals/supply & distribution, Health Personnel/organization & administration, 50207, Access to Essential Medicines and Health Technologies, Investments/economics, Decision Making, Risk Groups, Mutation/genetics, Betacoronavirus/genetics, Vaccine Potency, Clinical Trial, COVID-19, Ghebreyesus, Tedros Adhanom, Pfizer, Reino Unido, BioNTech, BNT162, Covax
Coletiva de imprensa: anúncios do Governo SP - 03/12/2020
Date:
03/12/2020
O Governador João Doria acompanhou nesta quinta-feira (03) a chegada de 600 litros a granel da vacina Coronavac, correspondente a um milhão de doses. Com esta remessa já são 1 milhão e 120 mil doses enviadas pela farmacêutica chinesa Sinovac ao estado de São Paulo.
“Ao lado do Jean Gorinchteyn, Secretário da Saúde do Estado de São Paulo e do Dimas Covas, Presidente do Instituto Butanta...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Epidemiological Monitoring, Quarantine/organization & administration, Social Isolation, Masks, Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/supply & distribution, Local Health Systems/organization & administration, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Risk Groups, Holidays, Vaccine Potency, Viral Vaccines/immunology, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech
Media briefing on COVID-19 - 16/10/2020
Date:
16/10/2020
See more details
Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Epidemiological Monitoring, Health Systems/organization & administration, Coronavirus Infections/drug therapy, Pneumonia, Viral/drug therapy, Chloroquine/therapeutic use, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Clinical Protocols, Dexamethasone/therapeutic use, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/immunology, Clinical Trial, Health Equity, Americas/epidemiology, Social Isolation, Masks, Hospital Bed Capacity, Intensive Care Units, Influenza, Human/immunology, Influenza Vaccines/immunology, Risk Groups, Health Promotion, Hypertension/prevention & control, COVID-19, Ghebreyesus, Tedros Adhanom, Covax
